<html>
<head>PUBMED IDs for LST-1</head>
<body bgcolor='#C5F0F2'><h1>LST-1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8547234/'>PVU II polymorphism of LST-1 (leucocyte specific transcript-1) in type I diabetes mellitus, Graves' disease and healthy controls.</a> June 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/10668961/'>Alternative splicing of the LST-1 gene located in the Major Histocompatibility Complex on human chromosome 6.</a> January 1  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/10668961/'>Alternative splicing of the LST-1 gene located in the Major Histocompatibility Complex on human chromosome 6.</a> January 1  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/10358072/'>Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1.</a> June 8  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10838093/'>Identification of organic anion transporting polypeptide 4 (Oatp4) as a major full-length isoform of the liver-specific transporter-1 (rlst-1) in rat liver.</a> June 6  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10903899/'>Cloning of the full-length coding sequence of rat liver-specific organic anion transporter-1 (rlst-1) and a splice variant and partial characterization of the rat lst-1 gene.</a> July 25  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11108274/'>The role of selenocysteine 133 in catalysis by the human type 2 iodothyronine deiodinase.</a> December 7  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/12196548/'>A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter.</a> August 28  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12859597/'>A Gambian TNF haplotype matches the European HLA-A1,B8,DR3 and Chinese HLA-A33,B58,DR3 haplotypes.</a> July 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/21963977/'>[Molecular cloning and functional characterization of a novel gene encoding human prostaglandin carrier, hPrC].</a> March 1  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21963936/'>Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals.</a> February 3  2011<br></body></html>
